J.P. Kleisbauer - Concepedia

Author

J.P. Kleisbauer

Also Known As

J P Kleisbauer, J-P Kleisbauer, J. Kleisbauer, J. P. Kleisbauer, J.-P Kleisbauer, J.-P. Kleisbauer, J.P. Kleisbauer, JG McVie, U G Svendsen

Publications

294

Citations

H-Index

Concepts

All Affiliations

J.P. Kleisbauer is an author at Hôpital Sainte-Marguerite specializing in oncology, radiation oncology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	168
2	Pharmacology	3	3	157
3	Health Sciences	2	2	50
4	Cancer Therapeutics	2	2	44
5	Pathology	1	1	33

J.P. Kleisbauer

Publications

183

Citations

H-Index

Page 1

	Year	Citations
Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study L. Goedhals, Jean‐François Héron, J.P. Kleisbauer, Annals of Oncology Emetogenic ChemotherapyOncologyMedicineMetronomic TherapyPharmacotherapy	1998	85
Is Navoban® (tropisetron) as effective as Zofran® (ondansetron) in cisplatin-induced emesis? Michel Marty, J.P. Kleisbauer, P. Fournel, Anti-Cancer Drugs Drug SafetyTherapeutic Drug MonitoringOncologyCisplatin-induced EmesisMedicine	1995	39
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy Fabrice Barlési, C. Tchouhadjian, C. Doddoli, British Journal of Cancer Clinical Surrogate MarkersPrognostic EvaluationPrognostic BiomarkersMedicinePharmacology	2004	33
Granisetron plus methylprednisolone for the control of high-dose cisplatin-induced emesis J.P. Kleisbauer, Mauro Antimi, M.C. Azevedo, Anti-Cancer Drugs	1998	15
41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC) Joan H. Schiller, Joachim von Pawel, Paul A. Clarke, Lung Cancer Cancer TherapeuticsMedicineMetronomic TherapyPreliminary ResultsBronchial Neoplasm	1997	11

Page 1